Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CAN'T WAIT FOR SYMTOMAX 1st CROP UPDATE!
GONNA BE A GOOD SUMMER!
WONKA ALL IN
TECHNICAL PENNY PLAYERS WILL START JUMPING IN
WITH SIZE SOON!
WONKA ALL IN
CUP N' HANDLE ON THE WAY TO GOLDEN CROSS
BY END OF JUNE.
WONKA ALL IN
CHARTS DON'T LIE.TREND REVERSING ON 1 YEAR CHART!
WONKA ALL IN
CHARTS DON'T LIE. GOLDEN CROSS AND TECHNICAL PENNY
TRADERS WITH HUGE BLOCKS COMING BY END OF JUNE.
LOVE IT OR HATE IT, JUST THE FACTS!
WONKA ALL IN
CUP&HANDLE, GOLDEN CROSS, NEWS? ,MAYBE ALL IN JUNE!
WONKA ALL IN
CHART LOOKING GREAT. TREND REVERSING. GOLDEN CROSS
COULD COME JUNE!
LOVE THIS VOLUME
WONKA ALL IN
HEY MIDAS,
I TOTALLY AGREE. THE IR FOR GCAN
SUCKS, THERE IS NONE.
CORONAVIRUS NO LONGER AN
EXCUSE. ENDLESS TALK OF SHARE
STRUCTURE CHANGES IRRELEVANT
HERE. THE ONLY THING THAT MATTERS NOW
IS WHEN ORALTAB.COM GOES HOT
AND STARTS FILLING ORDERS.
THAT IS ALL WE NEED!
WONKA ALL IN
ORALTAB.COM TWITTER ACCOUNT UPDATED WITH
IN DEPTH TRANSMUCOSAL DIAGRAMS OF ORALTABS
AND NOTICE OF COMING SOON 9 HRS. AGO.
WONKA OUT
NO, WHAT I MEANT WAS THAT WHEN I SAW THE Q,
I WAS FRANKLY DISGUSTED AT THE PART WHERE
IT STATED SYMTOMAX MADE NO SALES AS OF YET.
LAST NIGHT HOWEVER, I NOTICED A REVIEW FOR
THE 30 PACK ORALTABS AND THAT THE SITE SHOWED
PAYMENT CARD OPTIONS.
BEFORE I NOTICED THE CHANGES AND REVIEW
ON ORALTABS, I STARTED TO TAKE A DIFFERENT
PHILOSOPHY TOWARDS GCAN, AS THE Q. SUCKED.
BUT AFTER SEEING THE ORALTABS SITE MY OPINION
SWITCHED BACK TO LOOK AT GCAN AS A LONGER TERM PLAY
AGAIN.
I HAVE UNFORTUNATELY NOT SOLD A SHARE FOR
OVER A YEAR.
LATER
MY PROBLEM WITH GCAN IS THE IR SUCKS.
FOR A STOCK IN A HOT INDUSTRY WITH A
HOT PRODUCT THEY JUST SUCK AT GETTING
THEIR WORD OUT.
JMHO LIKE ANYBODY CARES RIGHT?!
WONKA ALL IN AGAIN
BTW, PAYMENT CARD OPTIONS SHOWING ON ORALTABS.COM!
SWEET DREAMS GCAN NATION
WONKA BACK ALL IN
WELL, ASSUMING THIS REVIEW IS LEGIT,
WE HAVE SALES!
TIMING HILARIOUS BUT WELCOME.
HERES TO ??
STAY WELL LONGS
FIRST REVIEW FOR ORALTABS 30 PACK BELOW!
1 review for Oral Tabs (Pack of 30) Berry Mint Flavour – 21mg CBD each tab
Rated 5 out of 5
Mark – May 18, 2020
Fantastic product, would recommend! I can definitely feel the difference with the Oral tabs and it tastes fantastic, better than i thought it would.
THAT BEING SAID, THE CONTRARIAN IN ME SAYS THIS IS
READY TO BLAST OFF, AS THEY MAKE NO ATTEMPT AT
EVEN OFFERING A RAY OF HOPE TO ENTICE SOME BUYING.
MAKING ME WONDER IF THEY DON'T WANT ANY FRENZIED BUYING
AS BIG NEWS IS COMING!
NEVER CAN FIND MY CRYSTAL BALL WHEN I NEED IT!
FOR THE MOMENT,
WONKA ALL IN
ONLY GOOD THING IN THIS REPORT IS THE FACT
THAT WE CAN'T GET ANY WORSE, SO FROM HERE WE CAN
ONLY GET BETTER. STOCK DIDN'T SELL OFF, WHICH IS
GOOD.
AITAN STILL A DOG$&@T CEO, NO SYMTOMAX SALES
AS OF THIS REPORT, AND NO UPDATES ON OTHER DEALS.
CORONAVIRUS CONCERNS ONLY RELEVANT TO THIS ONE
Q. IF THIS CONTINUES MUCH LONGER, I WILL SERIOUSLY
CHANGE MY INVESTMENT STRATEGY ON THIS TO ONE I'D
USE ON A REGULAR STOP SIGN , NO INFO, STINKY PINKY.
AS WELL, PHARMACEUTICAL, BIOTECH, AND HEALTH WELLNESS
COMPANIES GENERALLY ARE NOT UNDER THE RESTRANTS THAT
OTHER COMPANIES OPERATE UNDER THIS COVID CRAP.
CORONAVIRUS NO LONGER AN EXCUSE.
AITAN SHOULD NOT EVEN GET $1 A YEAR
AT THIS POINT.
TOTAL D-BAG
JUST TELLS ME WE WILL SEE ORALTABS OPEN
FOR BUSINESS SOONER RATHER THAN LATER!
AWESOME NEWS!
WONKA ALL IN
PROOOOOOOOOOOOVE IT!
PAALEEEEESE,
WONKA ALL IN
MORE ACTUALLY MEANINGFUL NEWS FOR GCAN LONGS!
PAUL SEGALS TWITTER FOLLOWING NOW AT
3470, UP FROM A FEW HUNDRED THREE WEEKS
AGO.
ARE THESE VENDORS FOR THE ORALTABS, AS
THERE IS A PICTURE OF THE ORALTABS
BOX ON HIS TWITTER FEED?
DUH,
AGAIN, LONGS AND FUTURE LONGS, THIS
IS WHAT MATTERS HERE, NOT WHAT
EMET DOES ON A DAILY BASIS.
DO YOUR OWN DD, SIZZLE MOVES
PENNIES, ANY PENNY PLAYER KNOWS
THESE PLAYS CAN DILUTE UNEXPECTEDLY
FOR DIFFERENT REASONS, BUT GCAN
WILL SIZZLE SOON, AND EMET IS
NOT RELEVANT TO THAT FACT!
JMHO
WONKA ALL IN
I'M NOT CONCERNED, AND I AM
CONFIDENT IN MY POSITION.
WONKA ALL IN
DID YOU TRY TO ORDER ONE, DO YOU LIVE IN EUROPE, DID YOU CALL SYMTOMAX OR ORALTABS
AS THEY HAVE INDIVIDUAL NUMBERS,
YES OR NO?!
LET US ALL KNOW WHAT HAPPENS!
AS ALWAYS,
WONKA ALL IN
GCAN ON THE CUSP OF MAJOR UPSIDE MOVE!
WONKA ALL IN!
TRUE, RELEVANT NEWS! ORALTABS WEBSITE UPGRADES!
CAN'T DENY THE TRUTH!
GO GCAN!
WONKA ALL IN
BLASTOFF IMMINENT!
WONKA ALL IN!
REAL NEWS! ORALTABS WEBSITE UPDATED!
SEE FOR YOURSELF, DONT TAKE MY WORD FOR IT!
WE ARE CLOSE GCANNERS!
WONKA ALL IN
AITAN ZACHARIN SUCKS WITH I.R. AND WEBSITE. JUST
SPEAKING THE TRUTH AS A LARGE SHAREHOLDER.
IF THEY HAD NEVER GOT THE SYMTOMAX DEAL,
PROBABLY WOULD HAVE BLOWN OUT OF THIS LAST
YEAR.
NOW I'M IN AND CONFIDENT IN THE FUTURE!
WONKA ALL IN
D&O 100% CORRECT ABOUT CUSTOMER RELATIONS &
WEBSITE.
WONKA ALL IN
GCAN 10 DAY AVG. VOL. 3.12 MILLION!
FOR THOSE WHO CARE ABOUT SUCH THINGS!
WONKA ALL IN
ORALTABS FOR PETS COMING SOON?
MAYBE, WHY NOT?
WONKA ALL IN
Pets have the same endocannabinoid system as humans, by which CBD enacts its effects on. Therefore, it's widely anecdotally supported that CBD used on our pets helps manage the same ailments we experience.
Learn more about Symtomax here: https://bit.ly/2yE8nw2
#Symtomax #CBD
WONKA ALL IN
NEED TO DO A PORTFOLIO SPRING CLEAN?
GET RID OF ALL YOUR DOGS! IF GCAN BARKS,
SELL IT AS WELL.
WONKA ALL IN
THINK THE ORALTAB IS FAKE, NOT
GONNA HAPPEN, PURE FANTASY?
SELL GCAN PLEASE, SALVAGE THE FEW
PENNIES YOU HAVE LEFT!
WONKA ALL IN
IF YOU DON'T LIKE THE SHARE STRUCTURE,
THINK THERE ARE BILLIONS OF SHARES
BEING SOLD BY THE COMPANY, YOU SHOULD
DUMP YOUR GCAN NOW!
WONKA ALL IN
THE ARTICLE I JUST POSTED WAS FROM 4-5 DAYS AGO.
ENOUGH PROOF FOR ME OUT THERE ANYWAY.
DISBELIEVERS SHOULD TAKE ADVANTAGE OF THIS HIGH
VOLUME AND SELL.
I WILL BUY IT!
WONKA ALL IN
EUROPE REOPENING AFTER COVID-19 SOON,
BACK TO BUSINESS, BACK TO PLANTING,
BACK TO HARVESTING, AND BACK TO THE
ORALTAB!
WONKA ALL IN
ONLY OBVIOUS THING HERE IS ORALTABS COMING SOON!
WONKA ALL IN
VOICE ONLINE > LIFESTYLE > HEALTH & WELLBEING > 21st April 2020 Written by: Joel Campbell
An introduction to medicinal cannabis
Paul Segal, chairman and co-founder of Symtomax, the biggest cannabis cultivation site in Europe, talks to the Voice Online
32
AIMS: Symtomax would like to foster improving education and create a more open discussion around medical cannabis
MEDICINAL CANNABIS is by no means a new phenomenon. After all, the cannabis plant has been incorporated into ancient medical treatments as a pain reliever for thousands of years.
However, it is only within the past decade or so that we have seen modern medicine begin to recognise its potential benefits.
Its popularity today, particularly in the form of CBD, is growing at pace thanks to strong interest from consumers. Indeed, The Centre for Medicinal Cannabis estimates that 1.3 million consumers are spending over £300 million per year on CBD products in the UK. This is larger than the total UK consumer spend on Vitamin D (£145 million) and Vitamin C markets (£119 million) combined. Yet despite such popularity, confusion still reigns about what the product actually is.
At a glance, the world of medical cannabis can seem complicated and overwhelming; with so many abbreviations for the various compounds, it can be difficult to get to grips with what the products actually contain. So, here is an introduction to medical cannabis, which, will help readers understand a little bit more about the products themselves and how they work.
Paul Segal
Starting with the source
To be able to understand the basics of medical cannabis, perhaps it’s best to start with the source.
Cannabis itself comes from, rather fittingly, the cannabis plant (also known as cannabis sativa). Whilst this might be an obvious point, interestingly the cannabis plant can produce over 140 naturally occurring chemical compounds known as cannabinoids. Of the various compounds produced by the plant, it’s THC (or, delta-9-tetrahydrocannabinol) and CBD (cannabidiol) which are most commonly used in medical cannabis.
However, both cannabinoids can have very different effects on the body, so it’s important to understand the difference between the two.
Knowing your CBD from your THC
The main difference to note is that CBD is a non-psychoactive compound, meaning it does not create the “high” effect often associated with cannabis. THC, on the other hand, is the primary constituent of cannabis that causes intoxicating effects; because of this, the volume of THC in medical cannabis products in the UK is limited to 0.2%.
Despite the associations of THC with recreational use, CBD is growing in popularity, thanks to claims of various therapeutic benefits. Indeed, proponents of CBD claim that it has wide-ranging benefits, from treating inflammation and pain, to reducing anxiety and insomnia.
There is a constant stream of scientific research being conducted to investigate all possible benefits it could present, with exciting developments emerging in this space on a regular basis.
Why are these abbreviations entering the mainstream?
Put simply, we’re hearing these abbreviations more and more because a greater number of consumers are taking the products and praising its benefits – particularly when it comes to CBD. Narrowing in briefly on the UK market, a recent ITV report from October 2019 revealed that around six million Brits have tried CBD bought in shops and online.
Indeed, people’s exposure to CBD has grown exponentially as the compound has made its way into everyday products. Dedicated CBD retailers, for instance, sell everything from CBD-infused shampoo to confectionary, while CBD coffees have cropped up on the menus of popular cafes.
These, however, represent commercial uses, rather than medical use-cases. CBD cannot currently be marketed as a medical product due to insufficient research; however, oils and capsules are being used by people as supplements in the hopes that it might relieve symptoms like pain and anxiety.
What does the future hold for medical cannabis?
It’s hard to overstate the speed with which CBD has entered the mainstream, and the volume of research currently being undertaken to uncover its effectiveness at treating medical ailments. For example, research published by Great Ormond Street Hospital in 2017 suggested that CBD reduces seizures by nearly 40% in children with a form of drug resistant epilepsy known as Dravet syndrome.
As this trend grows and CBD products reach more consumers, education is key. Arming the public with a good understanding about medical cannabis and how its various compounds are used will ensure safe, responsible use. It will also ensure consumer knowledge keeps pace with scientific developments in this space.
For instance, Symtomax are looking to launch their CBD Oral Tab in the early part of the year, which will offer an innovative delivery method. The unique route of administration through the inner lining of the mouth, not only improves the flexibility of time release but also increases the amount of medicine available to enter the blood stream. Whilst this is just one example, it highlights the rapid developments currently taking place in the medical cannabis industry.
Perhaps most importantly, improving education and creating a more open discussion around medical cannabis will bolster transparency and trust in the market. This will, in turn, prevent false expectations about what that product currently can and cannot do.
Paul Segal is the Chairman and co-founder of Symtomax. Symtomax have been approved by Infarmed to start the development of Europe’s largest medical cannabis facility. The company is dedicated to the production, research, cultivation, processing and distribution of medicinal cannabis oil to pharmaceutical companies worldwide.
32
Comments Form
Leave a Reply
Your email address will not be published. Required fields are marked *
*
*
*
SUBMIT
SUPPORT THE VOICE
The Voice Newspaper is committed to celebrating black excellence, campaigning for positive change and informing the black community on important issues. Your financial contributions are essential to protect the future of the publication as we strive to help raise the profile of the black communities across the UK. Any size donation is welcome and we thank you for your continued support.
SUPPORTSIGN-UP
An introduction to medicinal cannabisFIND YOUR NEXT JOB…
The ultimate events guide!
WHAT'S ON
COMMENT
How can a black officer with 36 years of unblemished service end up on a sex offender’s register?
SUPPORT THE VOICESUPPORTSIGN-UP
Terms & ConditionsPrivacy PolicyAbout UsContact Us
ENTWURF: Design & Build
Copyright 2020 © GV Media Group Ltd. All rights reserved.
By continuing to use this website you agree to our cookie policy
OK MORE INFO
COPIED FROM PAUL SEGALS TWITTER, ORALTABS BABY!
Paul Segal
@PaulSegal13
You ever wanted to try a new type of CBD delivery product. Don’t miss these Oral Tabs by Symtomax. Simply stick the tab to the inside of the mouth and allow for a slow release of a measured dosage of CBD.
Image
4:26 PM · Apr 23, 2020·Twitter for iPhone
I SAW THE FLAKES AS WELL! GOOD OMEN!
GO GCAN!
WONKA ALL IN
THOSE WHO BELIEVE THAT SHOULD PROBABLY SELL NOW!
WONKA ALL IN